PTX Pernix Therapeutics Holdings Inc.

0.48
+0.05  (+12%)
Previous Close 0.43
Open 0.44
Price To Book -0.03
Market Cap 6962807
Shares 14,505,848
Volume 2,067,035
Short Ratio
Av. Daily Volume 576,546

SEC filingsSee all SEC filings

  1. CT ORDER - Confidential treatment order 181220889
  2. 8-K - Current report 181198337
  3. 10-Q - Quarterly report [Sections 13 or 15(d)] 181174408
  4. 8-K - Current report 181174391
  5. 8-K - Current report 181151634

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Approved May 15, 2015.
TREXIMET
Adolescent migraine patients

SEC Filings

  1. CT ORDER - Confidential treatment order 181220889
  2. 8-K - Current report 181198337
  3. 10-Q - Quarterly report [Sections 13 or 15(d)] 181174408
  4. 8-K - Current report 181174391
  5. 8-K - Current report 181151634
  6. 8-K - Current report 181132809
  7. 8-K/A [Amend] - Current report 181114044
  8. 8-K - Current report 181039107
  9. S-8 - Securities to be offered to employees in employee benefit plans 181033034
  10. 10-Q - Quarterly report [Sections 13 or 15(d)] 181005334